Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.2K Hold
142
﹤0.01% 1890
2026
Q1
$14.9K Hold
142
﹤0.01% 1875
2025
Q4
$17.7K Buy
142
+92
+184% +$11K ﹤0.01% 1775
2025
Q3
$6K Sell
50
-1,026
-95% -$108K ﹤0.01% 2101
2025
Q2
$98.8K Sell
1,076
-1,650
-61% -$151K ﹤0.01% 1259
2025
Q1
$240K Buy
2,726
+2,193
+411% +$216K ﹤0.01% 1154
2024
Q4
$49.3K Buy
533
+47
+10% +$4.52K ﹤0.01% 1332
2024
Q3
$45.1K Buy
+486
New +$40.8K ﹤0.01% 1235
2023
Q4
Sell
-50
Closed -$2.74K 2109
2023
Q3
$2.74K Hold
50
﹤0.01% 1880
2023
Q2
$2.79K Buy
+50
New +$2.5K ﹤0.01% 1875
2020
Q2
Sell
-505
Closed -$12K 2570
2020
Q1
$12K Buy
+505
New +$17.3K ﹤0.01% 1715

Other funds holding CRH

Geneos Wealth Management's CRH Position: Q2 2026 in Review

Geneos Wealth Management held its CRH (CRH) position steady in Q2 2026 at 142 shares worth $15.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1890.

Geneos Wealth Management first reported a position in CRH in Q1 2020 and has held it in 11 quarters since. The position peaked at $240K in Q1 2025. 1,025 funds tracked by Wall St. Rank hold CRH as of Q2 2026.

  • Geneos Wealth Management held 142 shares of CRH worth $15.2K as of Q2 2026.
  • Geneos Wealth Management left its CRH share count unchanged in Q2 2026.
  • CRH made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #1890 holding.
  • Geneos Wealth Management first reported a position in CRH in Q1 2020 and has held it in 11 quarters since.
  • Geneos Wealth Management's CRH position peaked at $240K in Q1 2025.
  • 1,025 funds tracked by Wall St. Rank held CRH as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.